Intron A

Active Ingredient(s): Interferon Alfa-2b
FDA Approved: * October 4, 1983
Pharm Company: * SCHERING
Category: Hepatitis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Intron A Overview

Interferon alfa 2b is an antiviral or antineoplastic drug, that was originally discovered in the laboratory of Charles Weissmann at the University of Zurich. It was developed at Biogen, and ultimately marketed by Schering-Plough under the tradename Intron-A. It has been used for a wide range of indications, including viral infections and cancers. This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukemia, Behçet's disease, ch...

Read more Intron A Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Interferon_alfa-2b

Recent Intron A Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Interferon Alfa-2b
  • Injection: 10 millionIU, 10 millionIU/0.2ml, 10 millionIU/ml, 18 millionIU, 25 millionIU, 25 millionIU/2.5ml, 3 millionIU, 3 millionIU/0.2ml, 3 millionIU/0.5ml, 5 millionIU, 5 millionIU/0.2ml, 5 millionIU/0.5ml, 50 millionIU, 6 millionIU/ml
  • Vial: 10miu/vial, 18miu/vial, 25miu/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Intron A: (11 results)

Sorted by National Drug Code
  • 0085-0539 Intron a Kit by Merck Sharp & Dohme Corp.
  • 0085-0571 Intron a Kit by Merck Sharp & Dohme Corp.
  • 0085-1110 Intron a Kit by Merck Sharp & Dohme Corp.
  • 0085-1133 Intron a 19.2 ug/.5ml Intralesional; Intramuscular; Subcutaneous Injection, Solution by Merck Sharp & Dohme Corp.
  • 0085-1168 Intron a 11.6 ug/.5ml Intramuscular; Subcutaneous Injection, Solution by Merck Sharp & Dohme Corp.
  • 0085-1235 Intron a 19.2 ug/.2ml Subcutaneous Injection, Solution by Merck Sharp & Dohme Corp.
  • 0085-1242 Intron a 11.6 ug/.2ml Subcutaneous Injection, Solution by Merck Sharp & Dohme Corp.
  • 0085-1254 Intron a 38.4 ug/.2ml Subcutaneous Injection, Solution by Merck Sharp & Dohme Corp.
  • 0085-4350 Intron a Kit by Merck Sharp & Dohme Corp.
  • 0085-4351 Intron a Kit by Merck Sharp & Dohme Corp.
  • 0085-4352 Intron a Kit by Merck Sharp & Dohme Corp.

Other drugs which contain Interferon Alfa-2b or a similar ingredient: (6 results)

Related Intron A Topics:

Intron A
Cancer Drug...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA